0001127602-20-017158.txt : 20200519 0001127602-20-017158.hdr.sgml : 20200519 20200519161825 ACCESSION NUMBER: 0001127602-20-017158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200519 DATE AS OF CHANGE: 20200519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaPlume Joseph W CENTRAL INDEX KEY: 0001767215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 20893852 MAIL ADDRESS: STREET 1: 251 BALLARDVALE STREET CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1226 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-05-15 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001767215 LaPlume Joseph W 251 BALLARDVALE STREET WILMINGTON MA 01887 1 EVP, Corp Strategy & Develop Common Stock 2020-05-15 4 M 0 3350 73.70 A 22405 D Common Stock 2020-05-15 4 M 0 3000 88.05 A 25405 D Common Stock 2020-05-15 4 S 0 10519 167.9977 D 14886 D Common Stock 2020-05-15 4 S 0 4899 168.8104 D 9987 D Common Stock 2020-05-18 4 S 0 350 174.6511 D 9637 D Stock Options (Right to Buy) 73.70 2020-05-15 4 M 0 3350 0 D 2017-02-26 2021-02-26 Common Stock 3350 0 D Stock Options (Right to Buy) 88.05 2020-05-15 4 M 0 3000 0 D 2018-02-24 2022-02-24 Common Stock 3000 3985 D This transaction was executed in multiple trades at prices ranging from $167.54 to $168.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $168.605 to $169.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $174.62 to $174.6858. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Matthew Daniel as attorney-in-fact for Joseph W. Laplume 2020-05-19